High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy

Clinical trial NCT00747877 · UNKNOWN

Trial details

NCT number: NCT00747877
Sponsor: Leeds Cancer Centre at St. James's University Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2008-04-01
Primary completion: 2012-04-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.